Literature DB >> 10622459

Cholinergic-drug induced sicca syndrome in Parkinson's disease: a case report and a review of the literature.

S Hashimoto1, T Sawada, T Inoue, K Yamamoto, M Iwata.   

Abstract

A 67-year-old woman developed severe sicca manifestations after initial treatment of Parkinson's disease with an anti-cholinergic drug, which prompted us to look for the presence of Sjögren's syndrome. The results of sialography, labial salivary gland biopsy, Rose-Bengal test as well as the presence of antinuclear antibody were consistent with the diagnosis of Sjögren's syndrome. The sicca symptoms diminished by cessation of the anti-cholinergic drug, and the parkinsonian features were controlled by levodopa. We suggest that Sjögren's syndrome should be considered, if patients with Parkinson's disease complain severe xerostomia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10622459     DOI: 10.1016/s0303-8467(99)00060-8

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  1 in total

1.  Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism.

Authors:  Sharon Hassin-Baer; Yair Levy; Pnina Langevitz; Sasson Nakar; Michael Ehrenfeld
Journal:  Clin Rheumatol       Date:  2006-10-21       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.